[The strategy for chemotherapy-induced myelosuppression].
Myelosuppression is one of the most serious adverse effects induced by chemotherapy targeting solid tumors and hematological malignancies, and results in neutropenia, anemia and thrombocytopenia. In particular, prompt and appropriate treatments are required for febrile neutropenia, because that disease may be fatal.